Area of research
Molecular Biology · Oncology
Research interest
Research interests include Lipid Membrane Structure and Behavior, Drug Transport and Resistance Mechanisms, Protein Structure and Dynamics, and Hepatocellular Carcinoma Treatment and Prognosis.
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
A Nomogram Based on S100A7 and Clinicopathological Characteristics to Predict the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Study
Breast cancer cells and adipocytes in hypoxia: metabolism regulation
Genistein inhibits the release of pro-inflammatory substances from macrophages by suppressing potassium loss- and ROS-mediated caspase-1/gasdermin D pathway activation and pyroptotic cell lysis.
Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study
BACH1 encourages ferroptosis by activating KDM4C‐mediated COX2 demethylation after cerebral ischemia–reperfusion injury
TRIM27 ameliorates ischemic stroke by regulating NLRP3 inflammasome-mediated pyroptosis via the Akt/Nrf2/HO-1 signaling
Combining native mass spectrometry and lipidomics to uncover specific membrane protein–lipid interactions from natural lipid sources
Tumor necrosis factor α-induced protein 3 mediates inflammation and neuronal autophagy in Parkinson’s disease via the NFκB and mTOR pathways
Structural basis for lipid and copper regulation of the ABC transporter MsbA
Long non-coding RNA RPL34-AS1 ameliorates oxygen–glucose deprivation-induced neuronal injury via modulating miR-223–3p/IGF1R axis
[Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments].